Matinas BioPharma Holdings, Inc. MTNB NYSE

NYSE • Healthcare • Biotechnology • US • USD

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Matinas BioPharma Holdings, Inc. (MTNB), 포함 40 건 매수 및 0 건 매도. 내부자 매수 총액은 $7.11M 내부자 매도 총액은 RSU 보상.

최근 활동이 있는 주요 내부자에는 Neugeboren Edward, D An Evelyn, Smith Robin L. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — MTNB

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2025-04-30	Neugeboren Edward	Director	RSU 부여	11,600	$0.59	$6.84K	11,600
2025-04-30	D An Evelyn	Director	RSU 부여	11,600	$0.59	$6.84K	11,600
2025-04-30	Smith Robin L	Director	RSU 부여	11,600	$0.59	$6.84K	11,600
2025-04-30	Murphy Keith	Director	RSU 부여	11,600	$0.59	$6.84K	11,600
2025-04-30	Jabbour Jerome D	President and CEO	RSU 부여	70,100	$0.59	$41.36K	70,100
2025-04-08	Eide Robert J	10 Percent Owner	정보 매수	492	$0.59	$288.31	984
2025-04-08	Pembroke & Partners Llc	10 Percent Owner	정보 매수	492	$0.59	$288.31	984
2025-04-08	Sanitam Partners Llc	10 Percent Owner	정보 매수	703	$0.59	$411.96	1,406
2025-03-11	Neugeboren Edward	Director	알 수 없음	-	-	-	-
2025-03-11	Murphy Keith	Director	알 수 없음	-	-	-	-
2025-02-13	Smith Robin L	Director	알 수 없음	-	-	-	-
2025-02-13	Pembroke & Partners Llc	10 Percent Owner	알 수 없음	839,591	-	-	-
2025-02-13	Sanitam Partners Llc	10 Percent Owner	알 수 없음	2,399,318	-	-	-
2025-02-13	Eide Robert J	10 Percent Owner	알 수 없음	839,591	-	-	-
2025-02-13	Stern Adam K	10 Percent Owner	알 수 없음	4,798,636	-	-	-
2025-02-05	D An Evelyn	Director	알 수 없음	-	-	-	-
2023-12-15	Jabbour Jerome D	President and CEO	RSU 부여	3,500,000	$0.25	$864.5K	3,500,000
2023-12-15	Matkovits Theresa	Chief Development Officer	RSU 부여	1,300,000	$0.25	$321.1K	1,300,000
2023-12-15	Kucinski Keith A	Chief Financial Officer	RSU 부여	1,000,000	$0.25	$247K	1,000,000
2023-12-15	Ferguson James J. Iii	Chief Medical Officer	RSU 부여	1,200,000	$0.25	$296.4K	1,200,000
2023-12-15	Liu Hui	Chief Technology Officer	RSU 부여	1,000,000	$0.25	$247K	1,000,000
2023-12-15	Hoover Thomas	Chief Business Officer	RSU 부여	1,000,000	$0.25	$247K	1,000,000
2023-11-01	Wikler Matthew	Director	RSU 부여	437,244	$0.21	$91.3K	437,244
2023-11-01	Conrad Herbert J	Director	RSU 부여	437,244	$0.21	$91.3K	437,244
2023-11-01	Giordano Natasha	Director	RSU 부여	437,244	$0.21	$91.3K	437,244
2023-11-01	Scibetta James S	Director	RSU 부여	437,244	$0.21	$91.3K	437,244
2023-11-01	Ende Eric J	Director	RSU 부여	437,244	$0.21	$91.3K	437,244
2023-11-01	Corzo Kathryn Penkus	Director	RSU 부여	437,244	$0.21	$91.3K	437,244
2022-12-20	Jabbour Jerome D	President and CEO	RSU 부여	1,988,300	-	-	1,988,300
2022-12-20	Matkovits Theresa	Chief Development Officer	RSU 부여	625,000	-	-	625,000
2022-12-20	Kucinski Keith A	Chief Financial Officer	RSU 부여	625,000	-	-	625,000
2022-12-20	Ferguson James J. Iii	Chief Medical Officer	RSU 부여	625,000	-	-	625,000
2022-12-20	Liu Hui	Chief Technology Officer	RSU 부여	625,000	-	-	625,000
2022-12-20	Hoover Thomas	Chief Business Officer	RSU 부여	475,000	-	-	475,000
2022-11-14	Wikler Matthew	Director	RSU 부여	142,657	-	-	142,657
2022-11-14	Conrad Herbert J	Director	RSU 부여	142,657	-	-	142,657
2022-11-14	Giordano Natasha	Director	RSU 부여	142,657	-	-	142,657
2022-11-14	Scibetta James S	Director	RSU 부여	142,657	-	-	142,657
2022-11-14	Ende Eric J	Director	RSU 부여	142,657	-	-	142,657
2022-11-14	Corzo Kathryn Penkus	Director	RSU 부여	142,657	-	-	142,657
2022-06-22	Conrad Herbert J	Director	증여 (지급)	1,358,122	-	-	-
2021-12-31	Wikler Matthew	Director	RSU 부여	7,859	-	-	290,472
2021-12-14	Mannino Raphael J	Chief Scientific Officer	RSU 부여	275,000	$0.92	$253K	275,000
2021-12-14	Jabbour Jerome D	President and CEO	RSU 부여	1,658,100	$0.92	$1.53M	1,658,100
2021-12-14	Matkovits Theresa	Chief Development Officer	RSU 부여	500,000	$0.92	$460K	500,000
2021-12-14	Kucinski Keith A	Chief Financial Officer	RSU 부여	500,000	$0.92	$460K	500,000
2021-12-14	Ferguson James J. Iii	Chief Medical Officer	RSU 부여	587,600	$0.92	$540.59K	587,600
2021-12-14	Hui Liu	Chief Technology Officer	RSU 부여	275,000	$0.92	$253K	275,000
2021-12-14	Hoover Thomas	Chief Business Officer	RSU 부여	850,000	$0.92	$782K	850,000
2021-12-06	Hoover Thomas	Officer	알 수 없음	-	-	-	-